In our study, we confirm the presence of highly recurrent molecular alterations of the PIK3CA gene in position 1047, which likely constitute the driving genetic event in the pathogenesis of a subset of ER+/PR− breast cancers. This evidence concerns the gene ESR1 and breast cancer.